Generali Investments Cee, Investicni Spolecnost, A.S. Moderna, Inc. Transaction History
Generali Investments Cee, Investicni Spolecnost, A.S.
- $1.07 Trillion
- Q1 2025
A detailed history of Generali Investments Cee, Investicni Spolecnost, A.S. transactions in Moderna, Inc. stock. As of the latest transaction made, Generali Investments Cee, Investicni Spolecnost, A.S. holds 5,300 shares of MRNA stock, worth $136,051. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,300
Previous 5,300
-0.0%
Holding current value
$136,051
Previous $220 Million
31.82%
% of portfolio
0.01%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
875Shares Held
255MCall Options Held
24MPut Options Held
31.3M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.04 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$656 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$640 Million0.64% of portfolio
-
State Street Corp Boston, MA17.8MShares$456 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$191 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...